Cytel Opens Solara to General Release & Launches New Trial Optimization Solution for Biotechs

March 29, 2021

Cytel announces that its clinical trial design and statistical software solution Solara is now available for general release to the pharma industry. Solara is available in two formats: standalone SaaS product, and as part of a consultancy solution. The consultancy solution is directed to smaller biopharma companies, which may lack an in-house biostatistician to lead the clinical trial design process.

For more information, click here.